Crizotinib Impurity 6 | CAS 3026867-46-6 - Request Quote
Crizotinib Impurity 6
| SZ CAT No: | SZ-C148010 |
| CAS No | 3026867-46-6 |
| Mol.F. | C16H13Cl2FN4O |
| Mol.Wt. | 367.2 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Crizotinib Impurity 6 is chemically (R)-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-5-(1H-pyrazol-4-yl)pyridin-2-amine. Crizotinib Impurity 6 is supplied with detailed characterization data compliant with regulatory guideline. Crizotinib Impurity 6 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Crizotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 3026867-46-6
Purchase 3026867-46-6
Order 3026867-46-6
Enquire 3026867-46-6
price of 3026867-46-6
3026867-46-6 Supplier
3026867-46-6 Manufacturer
3026867-46-6 Exporter
buy high quality Crizotinib Impurity 6
Purchase Crizotinib Impurity 6
Crizotinib Impurity 6 suppliers
Crizotinib Impurity 6 manufacturers
Crizotinib Impurity 6 price
Order Crizotinib Impurity 6
Enquire Crizotinib Impurity 6
Crizotinib Impurity 6 cost
Crizotinib Impurity 6 Supplier
Crizotinib Impurity 6 Distributor
Crizotinib Impurity 6 for Method Validation
Crizotinib Reference Standard
Crizotinib Impurity 6 for ANDA Filing
Crizotinib Impurity 6 for Forced Degradation Studies
Crizotinib Impurity 6 Identification Standards
Crizotinib Impurity 6 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.